Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

TransMedics Group, Inc.

TMDX Clue Score83

United States Fiscal year ends December CIK 0001756262 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

15 insiders · 13 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Gerardo Hernandez

Chief Financial Officer

—

$1.25M (4) scheduled

−$1.25M

31,935

0.0921%

$2.61M

—

David Weill

Director

$109.06K (1)

$1.22M (2) scheduled

−$1.11M

16,392

0.0473%

$1.34M

+52.7%

Waleed H Hassanein

President & CEO

$1.00M (1)

—

+$1.00M

666,102

1.92%

$54.37M

+25.4%

Thomas J. Gunderson

Director

—

$722.38K (1) scheduled

−$722.38K

16,642

0.0480%

$1.36M

+764.5%

Anil P. Ranganath

See remarks

—

$555.86K (2) scheduled

−$555.86K

13,091

0.0378%

$1.07M

+45.3%

Nicholas Corcoran

See remarks

—

$412.63K (1)

−$412.63K

41,558

0.1198%

$3.39M

+96.9%

Stephanie Lovell

Director

—

$178.50K (1)

−$178.50K

5,788

0.0167%

$472.47K

+200.7%

Edwin Kania

Director

—

—

—

263,732

0.7606%

$21.53M

+2.0%

Tamer I Khayal

Chief Commercial Officer

—

—

—

36,042

0.1039%

$2.94M

+72.9%

Fernando N. Araujo

See Remarks

—

—

—

22,969

0.0662%

$1.87M

—

Giovanni Cecere

Chief Commercial Officer

—

—

—

19,057

0.0550%

$1.56M

+139.0%

Matthew S. Forsyth

See Remarks

—

—

—

15,409

0.0444%

$1.26M

—

Merilee Raines

Director

—

—

—

6,981

0.0201%

$569.86K

+262.6%

James R Tobin

Director

—

—

—

6,981

0.0201%

$569.86K

−65.0%

Edward M Basile

Director

—

—

—

5,788

0.0167%

$472.47K

+690.7%